NuVasive (NUVA) to Release Earnings on Monday
NuVasive (NASDAQ:NUVA) is set to issue its quarterly earnings data after the market closes on Monday, February 26th. Analysts expect the company to announce earnings of $0.56 per share for the quarter.
NuVasive (NASDAQ:NUVA) opened at $48.21 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.51 and a current ratio of 2.85. NuVasive has a 12-month low of $44.62 and a 12-month high of $81.68. The firm has a market cap of $2,457.17, a price-to-earnings ratio of 25.51, a P/E/G ratio of 1.36 and a beta of 0.50.
NuVasive declared that its Board of Directors has authorized a share buyback program on Tuesday, October 24th that authorizes the company to buyback $100.00 million in shares. This buyback authorization authorizes the medical device company to buy shares of its stock through open market purchases. Stock buyback programs are usually an indication that the company’s board believes its shares are undervalued.
TRADEMARK VIOLATION WARNING: “NuVasive (NUVA) to Release Earnings on Monday” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another publication, it was stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this story can be viewed at https://www.thecerbatgem.com/2018/02/19/nuvasive-nuva-to-release-earnings-on-monday.html.
Nuvasive, Inc is a medical device company. The Company focuses on developing minimally-disruptive surgical products and procedurally-integrated solutions for the spine surgery. Its product portfolio focuses on applications for spine fusion surgery, including biologics used to aid in the spinal fusion process.
Receive News & Ratings for NuVasive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NuVasive and related companies with MarketBeat.com's FREE daily email newsletter.